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Abstract: Escherichia coli ST131 is a clinical challenge due to its multidrug resistant profile and
successful global spread. They are often associated with complicated infections, particularly urinary
tract infections (UTIs). Bacteriocins play an important role to outcompete other microorganisms
present in the human gut. Here, we characterized bacteriocin-encoding plasmids found in ST131
isolates of patients suffering from a UTI using both short- and long-read sequencing. Colicins Ia, Ib
and E1, and microcin V, were identified among plasmids that also contained resistance and virulence
genes. To investigate if the potential transmission range of the colicin E1 plasmid is influenced by
the presence of a resistance gene, we constructed a strain containing a plasmid which had both the
colicin E1 and blaCMY-2 genes. No difference in transmission range was found between transformant
and wild-type strains. However, a statistically significantly difference was found in adhesion and
invasion ability. Bacteriocin-producing isolates from both ST131 and non-ST131 lineages were able to
inhibit the growth of other E. coli isolates, including other ST131. In summary, plasmids harboring
bacteriocins give additional advantages for highly virulent and resistant ST131 isolates, improving
the ability of these isolates to compete with other microbiota for a niche and thereby increasing the
risk of infection.
Keywords: ST131; E. coli; bacteriocins; plasmids; AmpC-beta-lactamase; UTIs; virulence
1. Introduction
Pathogenic Extraintestinal Escherichia coli (ExPEC), including the uropathogenic E. coli (UPEC)
pathotype, is often associated with urinary tract infections (UTIs) [1]. They carry a high number
of virulence factors such as adhesins, fimbriae, hemolysins, aerobactin and others that allow these
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bacteria to live in the human gut but also, to cause infections at other sites [2–4]. One of the survival
strategies of E. coli is the production of bacteriocins, a group of antibacterial peptides often encoded by
genes located on plasmids and able to kill normally closely related surrounding bacteria [5]. Although
not required for growth, they help to outcompete other microorganisms (bacteria and fungi) for the
limiting nutrients in the environment [6,7]. Colicins and microcins are the types of bacteriocins most
often found in pathogenic and in approximately 30% of commensal E. coli [8–10]. Colicin genes are
mostly located in operons, also containing the colicin immunity gene, important for neutralizing
its toxic effect on the producer strain, and the lysis gene required for colicin release. The operon is
activated by the SOS system [11]. In contrast, microcins are not inducible by the SOS system and are
not toxic to producer strains. Colicins have different ways of action. They can act by forming a pore in
the bacterial membrane, digesting bacterial DNA by their nuclease activity, or by interfering with cell
wall synthesis [5,12]. The presence of multiple bacteriocins in E. coli isolates is common and increases
their urovirulence [13] and the development of bacteremia of urinary tract origin [9].
Within the E. coli population, ST131 is one of the most successful lineages frequently causing
UTIs and bloodstream infections (BSIs). Their success is partially associated with the presence of
fluoroquinolone resistance (FQR), β-lactamases responsible for their ESBL phenotype and specific
virulence genes [14,15]. Among a diversity of beta-lactamases genes, blaCMY-2 is frequently identified.
It encodes for an AmpC type of β-lactamase that confers resistance to all β-lactam antibiotics except
the fourth-generation cephalosporins and carbapenems [16]. ST131 E. coli, frequently belonging to
phylogenetic group B2, are associated with a high virulence profile [17]. Due to this combination of
a high resistance and virulence profile, infections caused by the ExPEC ST131 are a serious threat
for patients. In addition, other successful and worldwide spread lineages, such as ST405 and ST648,
have been associated with antibiotic resistance [18]. As mentioned, the production of bacteriocins,
such as microcin, by ExPEC is associated with a more virulent profile of the bacterium [2]. Whole
genome sequencing (WGS) has been used to reveal the epidemiology and evolution of the ST131
lineage [19,20] and the role of mobile genetic elements (MGE) herein [21]. MGEs, particularly plasmids,
can be easily exchanged between isolates creating sub-lineage variants that become even more resistant
and virulent [22]. As mentioned, in E. coli, several bacteriocins are encoded by genes located on
plasmids and the presence of resistance genes and specific bacteriocins on single plasmids could
potentially contribute to the success of ST131 E. coli. However, to the best of our knowledge, there
are no studies that address the importance of plasmids encoding both resistance and bacteriocin
genes for the successful dissemination and virulence potential of this high-risk clones and only a
few studies have investigated the importance of bacteriocins with respect to the virulence of these
successful lineages. Therefore, our study aimed to investigate the bacteriocin in vivo activity in E.
coli isolates, focusing on successful lineages, particularly ST131, and to characterize resistance genes
and bacteriocin-encoding plasmids of ST131 E. coli isolated from clinical urine samples in an attempt
to reveal their role in the bacterial virulence. In addition, we also studied the association between
bacteriocins and the phylogenetic groups, and resistance and virulence profiles.
2. Materials and Methods
2.1. Bacterial Isolates and Bacteriocin Activity Assay
The isolates used in this study were obtained from urine samples of patients hospitalized in four
hospitals located in Rio de Janeiro, Brazil. E. coli isolates were identified using mass spectrometry (Bruker,
Bremen, Germany). Antibiotic susceptibility testing was performed using VITEK-2 (bioMérieux, Marcy
l’Etoile, France), for which isolates were cultured on cysteine lactose deficient medium agar plates
(CLED, BD, Heidelberg, Germany) until a cell density higher than 105 colony-forming units (CFU)
was obtained. Bacterial cells were stored at −80 ◦C in a Lysogeny Broth (LB, Merck, S.A.) with 20%
glycerol before being further analyzed. For this study, isolates were selected that belong to ST10, ST69,
ST73, ST131, ST475 and ST648 as they are the most prevalent STs in the Rio de Janeiro population. In
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addition, isolates containing a bacteriocin gene were selected for further analyses. For the bacteriocin
activity assay, the isolates were grown in 5 mL of LB (Luria Both) overnight at 37 ◦C. Subsequently,
5 µL of the bacterial suspension was added to LB agar plates containing E. coli isolates or the control
strain (E. coli K-12 MG1655) and plates were incubated overnight at 37 ◦C. Formation of an inhibition
zone (halo) around the producer indicated production of a bacteriocin by the isolate in the suspension
and sensitivity to it of the isolate already on the plate.
2.2. Short-Read Sequencing
DNA of the isolates was extracted using the UltraClean microbial DNA isolation kit (MO Bio
laboratories, Carlsbad, CA, USA) and library preparation was performed using the Nextera XT kit
(Illumina, San Diego, CA, USA) and the library was sequenced on a Miseq (Illumina), as described
previously [23]. The raw data were deposited in the European Nucleotide Archive under the project
number PRJEB23420.
2.3. Long-Read Sequencing
For the bacteriocin-producing ST131 isolates 5332, 5848 and 7078, whole genome sequencing (WGS)
was also performed using Oxford Nanopore Technologies (ONT, Oxford, UK) long-read sequencing.
DNA extraction was performed as mentioned above for the short-read sequencing. For this, several
library preparation kits were used: isolate 5848 was prepared using the 2D ligation sequencing kit
(SQK-LSDK208), isolates 5332 and 7078 were prepared with the Rapid Sequencing kit (SQK-RAD004)
according to the manufacturer instructions. The libraries were loaded onto two different flo-MIN106
R9.4 flow cells. The runs were performed on a MinION device (ONT). Base calling was performed
using Albacore v1.2.2 (ONT) with the r94_250bps_2d.cfg workflow for isolate 5848 and with Guppy
v3.2.2 (ONT) for the other two isolates.
2.4. Assembly, Annotation and Analysis
For the short-reads, de novo assembly was performed with CLC Genomics Workbench v12.0
(Qiagen, CLC bio A/S, Aarhus, Denmark) using the default settings and an optimal word-size.
Annotation was performed by uploading the assembled genomes onto the RAST server version 2.0 [24].
The ST and virulence genes were identified by uploading the assembled genomes in fasta format to the
Center for Genomic Epidemiology (CGE), MLST finder website (version 1.7) [25] and VirulenceFinder
(version 2.0) [26]. For the long-reads, we analyzed the quality of the data through Poretools v0.6.0 [27]
and transformed the fast5 files into fastq files using the same tool [27]. Subsequently, we performed
hybrid assemblies using Illumina short reads and ONT long reads using Unicycler v0.4.1[28]. To
visualize the assembly graphics, we used Bandage v0.8.1 [29].
2.5. Plasmid Analysis and Identification of Bacteriocin Genes
The plasmids incompatibility groups were identified by uploading the assembled files, generated
using the hybrid assembly approach described above, to PlasmidFinder (version 1.3) [26]. The plasmid
sequences were annotated automatically using the RAST server version 2.0 and manually using
CLC Genomics Workbench v12.0 (Qiagen, CLC bio A/S, Aarhus, Denmark). Subsequently, plasmids
were uploaded to BLAST (NCBI database) to identify the closest reference plasmids. Alignment of
plasmid sequences was done using Easyfig v2.2.3 [30] and DNA plotter [31]. The bacteriocin genes
present in the isolates were detected by BAGEL 3, by uploading the fasta files onto the online tool [32].
Plasmid mobility was analyzed by locating and typing the origin-of-transfer (oriT) regions using a
DNA structural alignment algorithm that finds minimal Euclidean distances and p-values between
query oriTs and target plasmids [33]. Potential transfer host ranges of the predicted MOB groups were
determined from a MOB-typed dataset [34].
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2.6. Bacterial Transformation Assay
Isolate 5848 (plasmid donor) was cultivated in LB supplemented with 100 µg/mL of cefotaxime
overnight at 37 ◦C. Then, plasmid extraction was performed using the innuPREP plasmid Mini Kit
(Analytikjena Jena, Germany) according to the manufacturer’s protocol. The plasmid was identified by
size selection on an agarose gel and isolated from it using the innuPrep gel extraction kit (Analytikjena,
Germany) according to the manufacturer’s protocol. After purification, the plasmid DNA was quantified
and used to transform E. coli Dh5α using CaCl2 and a heat shock, as previously described [35]. The
bacteria were plated onto LB agar plates containing cefotaxime (1 mg/L) (Mediaproducts, Groningen,
The Netherlands) and resistant colonies were considered to have successfully acquired the plasmids.
They were tested for the presence of the plasmid using gel electrophoreses and further submitted
to short- and long-read sequencing, as described above. The plasmid sequences from the recipient
were compared with the sequence of the plasmid identified in donor sample 5848. Annotation of the
plasmids’ hybrid assemblies was performed using RAST (version 2.0) [24] and manual annotation in
CLC Main Workbench.v11.0.1 (Qiagen, CLC bio A/S/Aarhus, Vedbæk, Denmark).
2.7. Competition Adhesion and Invasion Experiments
Bacteria-cell adhesion assays were performed using Human Embryonic Kidney (HEK293)cells
(ATCC®LGC), maintained in DMEM medium (ThermoFisher, Paisley, Scotland) containing 2% of fetal
bovine serum (VWR, Roden, The Netherlands). Cells were grown to form a monolayer in 24-well
plates and inoculated with different strains in triplicate. After incubation at 37 ◦C in a CO2 incubator
for 3 h, the cells were washed three times with phosphate-buffered saline (PBS) and then lysed using
PBS containing 0.1% Triton X-100. The lysates were collected, serially diluted and the dilutions were
plated onto TSB agar plates. Adhesion was calculated as the number of CFU/mL recovered per well.
For invasion, the cells were incubated for an additional 1.5 h with medium containing 100 µg/mL
kanamycin. After incubation, cells were lysed as described above, serially diluted and plated on LB
plates and the number of CFU was determined.
2.8. Competition Fitness Assay
To investigate if the presence of antibiotic resistance and colicin-encoding plasmids affect the
bacterial fitness, a relative fitness test was performed, as described previously [36] with some minor
modifications. Briefly, relative fitness was estimated by a pairwise competition assay for which isolates
were grown in M9 minimal medium for 24 h. Subsequently, a single colony was used to inoculated
M9 minimal medium for overnight growth at 37 ◦C. The initial cell density was measured by plating
different dilutions on both antibiotic-free LB agar and on LB agar supplemented with 1 mg cefotaxime
(A0 and B0). The next day, cultures of the bacteria were serially diluted in 0.9% NaCl in a 96-well plate.
Subsequently, the different dilutions were also plated on both an antibiotic-free LB agar and on LB agar
supplemented with 1 mg cefotaxime and incubated for 24 at 37 ◦C (A1 and B1). The relative fitness (W)
was calculated as the ratio of the Malthusian parameter of each competitor: WAB = MA/MB, where
MA = ln[A(1)/A(0)], MB = ln[B(1)/B(0)], A(0) and B(0) the estimated initial densities of A and B and
A(1) and B(1) the estimated densities of A and B after 24h. This experiment was repeated 8 times.
2.9. Statistical Analysis
For the adhesion, invasion and biological fitness assays, the results obtained for the isolates were
analyzed thought the Student’s t-test using GraphPad Prism v.7.04. The association between the
presence of bacteriocin genes with phylogenetic groups, virulence genes and antibiotic multidrug
resistance profiles were performed by the Fisher’s exact test using the GraphPad Prisma v.7.04. p-values
< 0.05 were considered as statistically significant (GraphPad Software, La Jolla, USA).
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2.10. Ethical Considerations
This study was submitted and approved on October 2015 by the Pedro Ernesto University Hospital
ethical committee 174 according to Brazilian legislation and received the following registration number:
CAAE number: 45780215.8.0000.5259. All the samples used in this study were obtained from patients
that signed a consent form in which the gave permission for the use of sample and data for this study.
3. Results
3.1. Bacterial Isolates and Bacteriocin Sensitivity Profile
A collection consisting of 69 E. coli isolates obtained from urine samples of hospitalized patients in
Brazil were included in this study, of which 41 belonged to phylogenetic group B2, 13 to phylogenetic
group D, 9 to phylogenetic group A, 5 to phylogenetic group B1 and 1 to phylogenetic group F. The
distribution of the phylogenetic groups over the different ST-types is indicated in Table 1. Three
bacteriocin-producing ST131 isolates were identified: fimH22-O25:H4 isolates 5332 and 5848 and
fimH30-O25:H4 isolate 7078. All three inhibited the growth of isolates belonging to other STs, as well
as isolates belonging to ST131 (Figure 1). The rates of sensitivity against bacteriocin-producing ST131
isolates per ST types were: 15.3% (n = 4) of ST131, 11.1% (n = 1) of ST69, 71.4% (n = 5) of ST10, 50%
(n = 2) of ST73, 25% (n = 1) of ST405 and 66.6% (n = 4) of ST648. Among singleton ST types, two
isolates were sensitive to the bacteriocin(s) produced by the three bacteriocin-producing ST131 isolates.
Whereas, 6419 was only sensitive to the bacteriocin produced by the H30-ST131 (7078) isolate, 7167 was
only sensitive to bacteriocins produced by the H22-ST131 (5332 and 5848) isolates. Among the other
ST types, our analysis revealed that isolates 6419 (ST414), 6492 (ST12), 9097 (ST95) and 9307 (ST91)
belonging to phylogenetic group B2; isolates 3921 (ST10), 5038 (ST58), 5306 (ST641), 7167 (ST1431)
and 6632D (ST453) belonging to phylogenetic group B1; and isolates 1825 (ST93) and 7500 (ST744)
belonging to phylogenetic group A were able to inhibit the growth of isolates from different ST types
(Figure 2). In particular, isolates 3921, 9097 and 9307 were able to inhibit the growth of the majority of
ST131 isolates. The rates of sensitivity against bacteriocin produced by non-ST131 isolates were 76.9%
(n = 20), 83.3% (n = 5), 55.5% (n = 5), 57.1% (n = 4), 50% (n = 2), 25% (n = 1) and 61.5% (n = 8) for ST131,
ST648, ST69, ST10, ST73, ST405 and singleton ST types, respectively.
Figure 1. Bacteriocin activity among ST131. The graph shows the bacteriocin activity of the three
bacteriocin-producer ST131 isolates against other isolates that belong to ST131, ST10, ST648, ST405,
ST73, ST69, ST297 and ST414. The * indicates the singleton isolates. The dark blue hits indicate the
isolates that were sensitive to bacteriocin and the grey hits indicate bacteriocin-resistant isolates.
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Figure 2. Bacteriocin activity among non-ST131 isolates. The graph shows the bacteriocin activity
of non-ST131 isolates against isolates from different ST types. The * indicates the singleton isolates.
Orange represents isolates that were sensitive to the bacteriocin produced by the non-ST131 isolates
and grey represents the bacteriocin-resistant isolates.
Table 1. Bacterial isolates, their ST types, serotypes and phylogenetic groups.
Isolates ID ST Type No of Isolates Serotype Phylogenetic Group
3218, 5332, 7018, 7104, 9260,3218,9581A,
5770D,6638, 1294D, 5848, 2102, 1710D,
9533D, 3528, 7078, 9893, 7974, 4233,
5420, 4006, 5976, 2206, 8565, 2724, 6202












1843,0107D, 6022, 2986,2993, 7002 ST648 6 O1:H6 B2
6050, 9602, 6161, 2877 ST405 4 O102:H6 D
3052, 9492, 7348, 2723A ST73 4 O6:H1, O22:H1 B2
9668 ST297 1 O86:H49 B2
9097 ST95 1 O50/O2:H7 B2
6419 ST414 1 O16:H5 B2
5038 ST58 1 O8:H25 B1
5306 ST641 1 O30:H25 B1
3921 ST101 1 O21:H21 B1
7167 ST1431 1 O8:H19 B1
6632D ST453 1 O23:H16 B1
1825 ST93 1 O7:H4 A
7500 ST744 1 O89:H10 A
6492 ST12 1 O4:H5 B2
9307 ST91 1 O39:H4 B2
1643 ST354 1 O25:H34 F
3.2. Distribution of Bacteriocin Genes among Clinical Isolates
Analyses of WGS data revealed the presence of bacteriocin genes encoding microcin V, pyocin S,
and the colicins A, Ia, Ib, M and E1 in our bacteriocin-producing isolates (Table 2). In the ST131 isolates
showing bacteriocin activity, i.e., 5332, 5848 and 7078, the colicin E1, Ia, Ib and the pyocin S genes
were present. Moreover, isolates 5848 and 7078 also contained a microcin V gene. ST131 isolate 7104
presented the colicin E1 and pyocin S genes, whereas all of the remaining ST131 isolates contained only
the pyocin S gene. In all ST73 isolates, the colicin E9 gene was identified and an additional bacteriocin
Microorganisms 2019, 7, 534 7 of 15
was identified in isolates 7348 (colicin-10), 2723A (colicin E1) and 9492 (pyocin S). ST10 isolates also
contained genes for different bacteriocins, such as a microcin B17 in isolate 6077, microcin V, colicin
A and colicin M in isolate 8874, colicin A and M in isolate 5217 isolate, and colicin E1 in isolate 8200.
Bacteriocin genes found in bacteriocin-producer isolates are listed in the Supplementary Table S1 and
Figure S1. No known bacteriocin genes were detected in ST69, ST405 and ST648 isolates.
Table 2. Distribution of bacteriocin genes among clinical isolates.




Ia Pore-forming 13 0
Ib Pore-forming 1 0
M Peptidoglycan Synthesisinhibitor 3 2
10 Pore-forming 0 1
A
E1 Pore-forming 3 7
E9 DNase 2 4
A Pore-forming 1 2
Pyocin S DNase 7 24
Microcin V Membrane disruption 4 1
Microcin B17 Membrane disruption 1 1
3.3. Association between Phylogenetic Group, Virulence Genes, MDR and Bacteriocins Genes
Our analysis revealed an association between phylogenetic group B2 and the presence of bacteriocin
genes (p = 0.0219). We also analyzed a possible correlation between the presence of bacteriocins and
68 different virulence genes and found a statistically significant association between the presence of
bacteriocins genes and the virulence genes iroN (p = 0.006), fyuA (p = 0.026), fhuA (p = 0.034), irp2 (p =
0.026), nleA (p = 0.012), sigA (p > 0.001) and ompT (p = 0.046). No statistically significantly association
was found between the MDR profile and the presence of bacteriocin genes.
3.4. Identification and Characterization of Plasmids Present in ST131 Isolates
To determine if identified colicin genes were located on the bacterial chromosome or on a plasmid,
a combination of short- and long-read sequencing of three ST131 isolates (5332, 5848 and 7078) was
used. Hybrid assemblies revealed the presence of three different plasmids in isolates 5332 and 5848, of
which two were also identified in isolate 7078 (Figure 3 and Supplementary Figure S2). The smallest
plasmid (6645 bp), designated here as p5848A1, belonging to replicon type Col156, contained the
colicin E1 gene operon, consisting of the colicin E1 gene and the genes encoding for its immunity and
lysis proteins, but no resistance genes. Other genes present on this plasmid were the mebA, mebB,
mebC, mebD genes, two genes encoding the entry exclusion proteins 1 and 2, and two genes encoding
hypothetical proteins (Figure 3A). The medium-size plasmid (101,573 bp), designated in this study as
p5848A2, belonged to incompatibility group IncI1. It mostly contained genes encoding for hypothetical
or mobile element proteins, but also the beta-lactamase gene blaCMY-2 flanked by the Colicin Ib and
the blc genes, the latter encoding for a membrane-associated lipoprotein. Other genes located on this
plasmid were the sugE gene, conferring resistance to quaternary ammonium compounds, tra genes
known to be involved in conjugation, the antitoxin genes phD and ccdA, the toxins genes doC and
ccdB, the umuC gene related with activation of the SOS system, and the psiB and psiA genes involved
in inhibition of the SOS system. In addition, transposases belonging to the IS200/IS605 family were
detected in this plasmid. This plasmid is very similar to the pSTM709 plasmid present in Salmonella
enterica subspecies Typhimurium (NCBI reference sequence: NC_023915.1) isolated from Uruguay,
except for three regions, one region (nt 2-408) absent in the p5848A2 plasmid and two regions (nt
38446-41078 and nt 101808-101573) only present in p5848A2 (Figure 3B and Supplementary Figure
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S3). Finally, the largest plasmid (149,732bp), designated here as p5848A3, belonged to incompatibility
groups IncFII and IncFIB and carried several genes, most of them specifying hypothetical proteins and
proteins associated with plasmid conjugation, transcriptional regulation, and mobile genetic elements.
It also contained virulence genes, including genes for iron uptake, such as the aerobactin genes iucAD,
the ABC iron transporter genes iroBN, the hemolysin gene hha, genes for the bacteriocins colicin Ia and
microcin V. Further, this plasmid carried antibiotic resistance genes, including tetracycline resistance
genes (tetA and tetR) and the trimethoprim resistance dfrA5 gene. Other genes present on this plasmid
encode the Macrolide-specific ABC-type efflux system (macA and macB) and ion transporters (copB,
merC, merE and merT) (Figure 3C).
Figure 3. ST131 plasmid sequence alignments using hybrid assemblies. (A) Sequence alignment of
plasmid p5848A1 found in isolates 5332, 5848 and 7078 containing the colicin E1 gene. (B) Alignment of
plasmid p5848A2 found in isolates 7078, 5332 and 5848, containing the beta-lactamase blaCMY-2, the sugE
and the colicin Ib genes. (C) Alignment of plasmid p5848A3 found in isolates 5332 and 5848, containing
the colicin Ia and microcin V genes, the resistance genes dfrA5, tetA and tetR and the virulence genes
iucA, sitA, iroB, iroC, iroD and iroE. Isolate 5332 is indicated in pink, 5848 in green and 7078 in light
purple. In addition, blue indicates the coding sequence region (CDS), black indicates the GC content,
yellow indicates regions with a positive GC skew, and dark purple yellow indicates regions with a
negative GC skew.
3.5. Bacterial Fitness Cost and Predicted Transfer Potential
We decided to investigate the potential effect of bacteriocins on the maintenance and transmission
of plasmids that also contain antibiotic resistance genes. We constructed a transformant strain Dh5α +,
containing a plasmid that combines the blaCMY-2 flanked by a gene encoding a hypothetical protein
and the blc and sugE genes, recombined with the ColE1 plasmid p5848A1, here designated p5848A1.2
(accession number: PRJEB34226) (Supplementary Figures S2 and S3). First, we assessed the fitness
cost of carrying bacteriocin- and resistance gene-encoding plasmids, and calculated the relative fitness
using the ratio of the Malthusian parameter. The relative fitness of DH5α+ ranged from 0.211–0.95
and no statistically significant difference in the growth rate was observed between the control sample
DH5α and the transformant strain DH5α+ (Figure 4). We predicted plasmid mobility using the oriT
regions by MOB typing [36]. Our results showed that plasmid p5848A1.2 belongs to MOB group P,
similar to the ColE1 plasmid p5848A1. Therefore, there is no indication for a difference in transfer
range among the plasmid containing a bacteriocin and the one containing both a bacteriocin and a
cephalosporin resistance gene. In addition, plasmid p58548A2 that also contains genes for colicin Ib
and cephalosporin resistance, belongs to the same MOB group P, while plasmid p5848A3 that encodes
colicin Ia, microcin V and other resistance genes belongs to the MOB group F (Table 3).
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Figure 4. Growth rate of isolates with or without bacteriocin and resistance genes containing plasmids
in the presence or absence of cefotaxime. Results showing the growth rate (UFC/mL) of each competitor.
Squares, triangles and circles indicate replicates. No statistically significant difference was found when
comparing growth rates of DH5α (wild type) and DH5α+ (transformant strain).
Table 3. Results of the prediction of transfer range using origin-of-transfer.
Plasmid ID Nic Location Orientation MOB Subgroup NIC p-Value
P5848A1 2350 RC P −92.6330 <10−16
P5848A1.2 8823 F P −56.5174 <10−16
P5848A2 45897 RC P −377522 <10−16
P5848A3 110908 F F −48.8684 <10−16
MOB: mobility groups; nic: relaxase enzyme nicking sites (region within the origin transfer). F, forward; RC,
reverse complement.
3.6. Bacteriocin-Encoding Plasmids and Phenotypical Virulence Profile
We investigated if the presence of plasmids affects the virulence profile of isolates through testing
the ability to adhere and invade urinary tract epithelial cells. As expected, our results showed that
the bacteriocin-producing isolates 5848, 5332 and the DH5α+ (transformant) had a higher adherence
to HEK-293 cells, compared to the negative control (DH5α). However, from the non-bacteriocin
producing isolates only isolate 1643 showed a statistically significant lower adherence compared to
isolate 5332 (p = 0.0429) and no other statistically significant differences were observed. Similar results
were found for the invasion ability where no differences were found for colicin-producing isolates
compared to non-colicin-producing ones. However, the DH5α+ (transformant) strain presented a
significant increase in the ability to adhere and invade the urothelial cells (p = 0.0001) compared to the
control DH5α strain, presenting similar results as found for isolates 5332 and 5848 (Figure 5A,B).
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Figure 5. Competitive adhesion and invasion assay. (A) Adhesion to HEK-293 (human embryonic
kidney cell line) calculated in CFU/mL. (B) Invasion of HEK-293 for the same isolates. In both assays,
results obtained from the plasmid containing isolates 5332 and 5848 were compared with other ST131
clinical isolates (9581A, 2206, 0107D), with ST648 (2993), ST354 (1643), ST297 (9668) and ST69 (7719)
isolates, and with both the parental DH5α and the transformant DH5α+ strains. The * indicates a
statistically significant difference (p ≤ 0.05).
4. Discussion
Bacteriocins are mediators of intra- and interspecies interactions. Whereas recent studies have
focused on bacteriocins as a potential replacement for antibiotic therapy, their potential as a virulence
factor for specific successful E. coli lineages remains poorly investigated [9,37,38]. In the present
study, we investigated the bacteriocin activity of clinical E. coli isolates obtained from urine samples of
patients hospitalized in Brazil, with a focus on ST131. Three clinical ST131 E. coli isolates contained
plasmids with bacteriocin genes (colicins E1, Ib, Ia, and microcin V). Two of the isolates belonged to
the fimH22 and serotype O25:H4, while another isolate was identified as fimH30 and O25:H4. The
H22-ST131 sublineage is frequently isolated from UTIs and, because it was also detected in poultry, it
is considered as a foodborne uropathogen [39]. The H22-ST131 isolates from poultry and the isolates
in this study shared the presence of a bacteriocin-containing plasmid. Interestingly, the H30-ST131 E.
coli isolate containing colicin E1 and Ib genes located on plasmids, was sensitive for fluoroquinolones
and cephalosporins, whereas both H22-ST131 isolates were AmpC-β-lactamase-producing and one of
them (5332) was fluoroquinolone-resistant. Horizontal transfer of the plasmid between isolates within
the same geographic area could have occurred. However, also many ST131 isolates were circulating in
the same area without these plasmids. Therefore, the presence of similar plasmids in both resistant
H22-ST131 and susceptible H30-ST131 isolates could also be explained by the fact that H30 strains
evolved from the H22 lineage [21].
In our study, the presence of plasmids carrying colicin Ia, Ib and E1, and microcin V genes, in the
ST131 isolates, was the most likely cause of their ability to inhibit the growth of other E. coli isolates.
Our results show that colicin produced by ST131 isolates was able to kill other ST131 isolates resulting
in strain–strain competition. This result agrees with findings in previous studies showing that colicins
act mainly against closely related E. coli isolates [12,38]. Our results also show that a higher number
of the investigated ST131 isolates is sensitive to the bacteriocin(s) produced by non-ST131 isolates
than for bacteriocin(s) produced by the ST131 isolates. This is in contrast with previous studies that
reported bacteriocin insensitivity of isolates belonging to phylogenetic group B2, to which ST131 also
belongs [40]. However, another study pointed out that this insensitivity to bacteriocins of ST131 may
have been overestimated and is related to the O-antigen [41].
Plasmid p5848A1 containing the colicin E1 gene has a similar structure as other colicin E1
containing plasmids, including the presence of the meb operon, which plays a role in conjugation
similar to the traY genes of IncF plasmids [42]. The plasmid p5848A2, containing colicin Ib, was found
to be highly similar to a plasmid (pSTM709) present in Salmonella enterica subspecies Typhimurium
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isolated in Uruguay, but had two additional regions encoding mobile elements, hypothetical proteins,
and the RepY and InC proteins, that are absent from the pSTM709 plasmid. The presence of colicin
Ib conferred a competitive advantage in the gut to Salmonella enterica [10]. The presence of genes
encoding the membrane lipoprotein blc and the efflux pump sugE flanking the beta-lactamase blaCMY-2
gene, is similar to the structure identified for other plasmids among pAmpC-producing E. coli from
poultry and fecal human samples [43]. The largest plasmid p5848A3, harboring both resistance and
virulence genes, carries the colicin Ia and microcin V genes. Notably, colicin Ia is induced by the SOS
system, while the microcin V is induced by iron-limited conditions. The same plasmid also carries
several genes for iron uptake, consistent with a previously described association between siderophores
and salmochelin [13]. The combination of these genes on the same plasmid may give an advantage to
survive in and to colonize iron-limited environments as the urinary tract. Furthermore, the presence of
colicin Ia and microcin V genes on the same plasmid was described in another study as a non-aleatory
evolution that may have happened to increase the killing range and/or to increase the fitness advantage
of bacteria in different environments [44].
Eleven non-ST131 isolates were identified, which have the ability to inhibit the growth of isolates
from different ST types. The bacteriocin genes among ST131 isolates were less diverse than those
in non-ST131 isolates, which is in agreement with previous findings [2]. Interestingly, despite the
resistance of ST69 and ST405 to bacteriocins, we did not identify any bacteriocin genes nor did we
find any other known genes related to bacteriocin resistance in these groups. Therefore, it would be
highly interesting to investigate the mechanism(s) behind the observed resistance in future research.
Furthermore, we identified a statistically significant association between the presence of bacteriocin
genes and the phylogenetic group B2 among our isolates. These results are different from previous
findings showing such an association also for isolates belonging to phylogenetic group D [2,45].
However, our phylogenetic group D isolates did not contain any known bacteriocin genes.
In our study, colicin E1 genes were identified in both bacteriocin-producing and non-producing
ST131 isolates. This colicin has already been described to be a potential virulence factor for
uropathogenic E. coli strains and is frequently found in UPEC [46]. The colicin Ib gene was identified
in all ST131 bacteriocin-producing isolates in our study and was found before to play a role in the
competition with intestinal E. coli [10]. Together with the colicin Ia and microcin V, these bacteriocins
are highly frequent in successful clones causing symptomatic and asymptomatic UTIs [47]. The
presence of bacteriocin-encoding plasmids may increase the survival and help compete against other
E. coli in the gut, resulting in colonization of the gut by these sublineages, thereby increasing their
risk to cause UTIs, particularly, because UTIs can start with the contamination of the periurethral
region by bacteria present in the gut [48]. Such association between high colonization rates and UTIs
was already described for the beta-lactamase-producing O25:H4 ST131 clone [47]. In addition, the
presence of bacteriocin(s) in high-risk clones can lead to long-term colonization and persistence of
ESBL-producing ST131 E. coli [49,50].
Previous studies reported the importance of plasmids in the evolution of sublineages, particularly
the highly resistant and virulent H30Rx-ST131 [21]. The presence of both bacteriocin- and resistance
gene carrying plasmids in H22 and H30 ST131 isolates may increase the chance of spread of those
plasmids among the more antibiotic resistant sublineages as H30-R and H30Rx-ST131 or less resistant
H41 and enhance the chances for the emergence of other high-risk sublineages. It has been shown
that the evolution of successful lineages such as ST131 is driven by the efficiency of obtaining a
high-resistance and -virulence profile with less metabolic stress, i.e., with lower fitness cost. We
identified a positive association between the presence of some virulence and bacteriocin genes. This
result is consistent with previous studies that showed an association between the presence of common
virulence genes and bacteriocin genes in UPEC [9,13]. Most of the virulence genes associated with
bacteriocins in our study were iron uptake genes, supporting the view that the fyuA and iroN genes
are associated with different bacteriocins [51]. In addition, we did not identify a positive association
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between the MDR profile and the presence of bacteriocin genes, which is in agreement with the results
of a previous study [9].
Through phenotypical analysis, we investigated whether the presence of plasmids encoding
resistance, bacteriocins and other virulence factors affects the adhesion and invasion ability to
uroepithelial cells, which are key events in UTIs’ pathogenesis [48,52]. Our results show that the
presence of three bacteriocin-encoding plasmids seems not to affect the adhesion and invasion ability,
since no significant difference was found between the bacteriocin-producing isolates and most of
the non-bacteriocin producing isolates. Further, we investigated whether the presence of plasmids
containing resistance and bacteriocin genes could improve the virulence of the bacteria without
affecting the spread and maintenance of this plasmid. For this, we constructed a DH5α strain (DH5α
+), containing a ColE1 plasmid (p5848A1.2), carrying both the blaCMY-2 and colicin E1 genes. This
strain showed a significant increase in the ability to adhere and invade urothelial cells compared to the
parental DH5α strain. Also, a previous study showed that the carriage of ESBL-encoding plasmids
improves the virulence in some strains [53]. In addition, a higher copy number of the plasmid in the
transformant strain compared to that of the plasmid in clinical isolates, and thus a higher expression
of the bacteriocin gene located on it, may be associated with an increase in virulence. However,
no difference in virulence was observed between the transformant strain and the clinical isolates.
Moreover, the presence of this plasmid does not seem to increase the overall bacterial fitness cost.
Furthermore, the original plasmid containing the colicin E1 (p5848A1) and the modified plasmid
containing the colicin E1 and blaCMY-2 genes belong to the same MOB subtype and, therefore, are
expected to have the same transfer range. This means that the acquisition of a resistance gene seems
not to affect the structural properties of the transfer range. These results are in agreement with previous
findings showing that ColE1 plasmids are important vehicles for antibiotic resistance and other traits
in Enterobacteriaceae [42]. Together, the presence of ESBL and bacteriocin plasmids in E. coli ST131
isolates could improve the bacterial competition ability and resistance without an increase in the fitness
cost, which would make the transmission of these plasmids more likely.
5. Conclusions
In summary, the combined presence of resistance genes, such as the beta-lactamase blaCMY-2 gene,
and bacteriocin-containing plasmids in highly resistant and virulent E. coli ST131 high-risk isolates is a
concern, as it may result in increased colonization rates, thereby enhancing the chances for causing
UTIs. The fact that these plasmids do not reduce the adherence and invasion potential and do not
come with a high fitness cost, increases the chance of spread, including spread to other bacterial species
and to already difficult-to-treat sublineages of ST131, such as H30Rx-ST131. Despite the fact that the
virulence potential of isolates carrying these plasmids still needs to be further evaluated in vivo, their
identification and characterization using molecular approaches are undoubtedly important to monitor
the evolution of these high-risk clones.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/7/11/534/s1,
Table S1. Bacteriocin genes identified among ExPEC isolates. Figure S1. Bacteriocin genes identified among the
bacteriocin producer-isolates. The orange squares indicate the presence of colicin genes in the isolates, while the
green squares indicate the presence of microcin genes in these isolates and the diagonal down borders indicate the
absence of these genes. Figure S2. Plasmids Sequences (A) completely annotated sequence of plasmid p5848A2,
highlighted in blue are the antibiotic resistance gene beta-lactamase blaCMY-2, the blc and sugE genes, the colicin Ib
gene, and the imm gene encoding the immunity protein; (B) Complete sequence of the plasmid p5848A1 indicating
the E1 colicin gene, the imm gene encoding the immunity protein and the gene encoding the colicin E1 precursor
lysis protein; (C) completely annotated sequence of plasmid p5848A3, highlighted in blue are the antibiotic
resistance and virulence genes, and the colicin Ia and microcin V genes; (D) the complete sequence of plasmid
p5848A1.2, containing the antibiotic resistance gene beta-lactamase blaCMY-2, the blc and sugE genes, and the
colicin Ib gene. Figure S3. Alignment of plasmids p5848A2 and pSTM709. Alignment of plasmid p5848A2 present
in isolates 5332 and 5848 and pSTM709 (HG428759) present in Salmonella enterica isolated in Uruguay. The orange
trapeziums in the lower part of the figure represent the regions present in plasmid p5848A2 but absent from the
Salmonella enterica plasmid pSTM709. Figure S4. Comparison of plasmids p5848A1 and p5848A2.1. Alignment of
plasmids p5848A1 present in the isolates 5848 and 5332 and the p5848A1.2 plasmid present in the Dh5α+ mutant
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after recombination. The fragment containing the resistance gene and the flanked genes that recombined with
p5848A1 plasmid is highlighted in yellow.
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51. Starčič Erjavec, M.; Petkovšek, Ž.; Predojević, L.; Žgur-Bertok, D. Iron uptake and bacteriocin genes among
Escherichia coli strains from skin and soft-tissue infections. Apmis 2017, 125, 264–267. [CrossRef]
52. Lewis, A.J.; Richards, A.C.; Mulvey, M.A. Invasion of Host Cells and Tissues by Uropathogenic Bacteria.
Microbiol. Spectr. 2017, 26, 2–29.
53. Schaufler, K.; Semmler, T.; Pickard, D.J.; De Toro, M.; De La Cruz, F.; Wieler, L.H.; Ewers, C.; Guenther, S.
Carriage of extended-spectrum beta-lactamase-plasmids does not reduce fitness but enhances virulence in
some strains of pandemic E. coli lineages. Front. Microbiol. 2016, 7, 336. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
